| scholarly article | Q13442814 |
| P50 | author | Hirofumi Akari | Q38324069 |
| P2093 | author name string | Adachi A | |
| Kawamura M | |||
| Amano K | |||
| Ogasawara T | |||
| Hatanaka M | |||
| Inubushi R | |||
| Shimano R | |||
| Furuta RA | |||
| P2860 | cites work | Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 |
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus | Q37546388 | ||
| Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation | Q37577496 | ||
| Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy. | Q39869106 | ||
| Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. | Q40044520 | ||
| Compatibility of rev gene activity in the four groups of primate lentiviruses | Q41663845 | ||
| DNA transfection of mouse lymphoid cells by the combination of DEAE-dextran-mediated DNA uptake and osmotic shock procedure | Q41747241 | ||
| Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines | Q42803460 | ||
| Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression | Q44389543 | ||
| HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus | Q45843803 | ||
| Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. | Q53436850 | ||
| Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function | Q58611466 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 231-234 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | HIV-1 capsid mutants inhibit the replication of wild-type virus at both early and late infection phases | |
| P478 | volume | 415 |
| Q39214476 | A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells |
| Q35750243 | A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein |
| Q42546287 | A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle |
| Q36627951 | Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope |
| Q40839431 | Cell-dependent gag mutants of HIV-1 are crucially defective at the stage of uncoating/reverse transcription in non-permissive cells |
| Q38859491 | Cell-dependent replication potentials of HIV-1 gag mutants |
| Q41001968 | Complete inhibition of SIVmac replication by its capsid mutants |
| Q39604838 | Cyclophilin A-independent replication of a human immunodeficiency virus type 1 isolate carrying a small portion of the simian immunodeficiency virus SIV(MAC) gag capsid region |
| Q47211742 | HIV evolution: CTL escape mutation and reversion after transmission |
| Q33717297 | Inhibition of HIV/SIV replication by dominant negative Gag mutants |
| Q40326740 | Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. |
| Q37086413 | Nucleocapsid protein function in early infection processes |
| Q33814996 | Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein |
Search more.